Lastly, PCI-34051, in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) variants, has synergistic apoptotic effects in TRAIL-resistant colon cancer cells (DLD-1, WiDr) [133]. Here, TNFSF10 is linked to malignant colon neoplasm.